Literature DB >> 9924068

Effect of flutamide on survival in patients with pancreatic cancer. Study needs to be repeated on a much larger scale.

S Bramhall, J Buckels.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9924068      PMCID: PMC1114789     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

2.  Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater.

Authors:  K E Bakkevold; A Pettersen; B Arnesjø; B Espehaug
Journal:  Br J Surg       Date:  1990-07       Impact factor: 6.939

3.  Accuracy of death certification in an autopsied population with specific attention to malignant neoplasms and vascular diseases.

Authors:  L W Engel; J A Strauchen; L Chiazze; M Heid
Journal:  Am J Epidemiol       Date:  1980-01       Impact factor: 4.897

4.  Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double blind, placebo controlled trial.

Authors:  B A Greenway
Journal:  BMJ       Date:  1998-06-27

5.  A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.

Authors:  J J Keating; P J Johnson; A M Cochrane; B G Gazzard; N Krasner; P M Smith; P N Trewby; P Wheeler; S P Wilkinson; R Williams
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.